Biblio Discovery — Demo Discovery Service

33 results for "Gregory Piazza"

Showing 1–20 · 0.91 seconds · RSS

  1. Journal Article

    Barriers to stroke prevention in Atrial Fibrillation: Insights from the global anticoagulation Roundtable

    Geoffrey D. Barnes; Gregory Piazza; Tze-Fan Chao et al.

    International Journal of Cardiology: Heart & Vasculature, Vol. 42 · 2022 · English · DOAJ Scopus

    Atrial fibrillation (AF) accounts for one-quarter of the global ischemic stroke burden. Population growth and an increasing prevalence of stroke risk factors underscores the critical need to recognize and address the worldwide crisis in underutilization of antithrombotic therapy for patients with…

  2. Journal Article Full text

    Arterial Thrombotic Complications in COVID-19: A Case of Renal Infarction

    Mariangela Mancini; Gianmarco Randazzo; Gregory Piazza et al.

    Biomedicines, Vol. 10 No. 10 · 2022 · English · DOAJ Scopus

    COVID-19 infection has been associated with thrombotic complications, especially venous thromboembolism. Although arterial thrombotic complications are rarely seen in these patients, we report the case of a 43-year-old patient who developed thrombosis of the main branch of the left renal artery…

  3. Journal Article

    The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents

    Galit H. Frydman; Michael B. Streiff; Jean M. Connors et al.

    TH Open, Vol. 04 No. 04 · 2020 · English · DOAJ

    SARS-CoV-2 infection (COVID-19) results in local and systemic activation of inflammation and coagulation. In this review article, we will discuss the potential role of coagulation factor Xa (FXa) in the pathophysiology of COVID-19. FXa, a serine protease, has been shown to play a role in the…

  4. Journal Article

    Direct oral anticoagulants in cancer-associated venous thromboembolism: trial robustness and clinical trade-offs

    Marco Zuin; Cecilia Becattini; Maria Cristina Vedovati et al.

    Research and Practice in Thrombosis and Haemostasis, Vol. 10 No. 5 · 2026 · English · DOAJ Scopus

    Background: Although direct oral anticoagulants (DOACs) are often favored over low-molecular-weight heparin for cancer-associated thrombosis, the robustness of trial evidence supporting their use remains uncertain. Objectives: We evaluated the efficacy, safety, and statistical robustness of DOACs…

  5. Journal Article

    Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis

    Craig I. Coleman; Gregory Piazza; Veronica Ashton et al.

    TH Open, Vol. 04 No. 04 · 2020 · English · DOAJ

    Background Extended duration thromboprophylaxis (ET) for approximately 30 days can effectively and safely reduce venous thromboembolism (VTE) risk in appropriately selected medically ill patients. We sought to estimate the proportion of hospitalized medically ill patients potentially qualifying for…

  6. Journal Article

    Trends in Bicuspid Aortic Valve–Attributable Death in the United States From 2010 to 2020

    Marco Zuin; Umberto Campia; Kim I. De la Cruz et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 21 · 2025 · English · DOAJ Scopus

    Background Population‐based data on bicuspid aortic valve (BAV)‐attributable mortality trends in the United States are limited. This study assessed trends in BAV‐attributable death in the United States from 2010 to 2020, evaluating differences by sex, ethnicity, urbanization, and census region…

  7. Journal Article

    Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea

    Ida E. Albertsen; Jesper Bille; Gregory Piazza et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 13 No. 8 · 2024 · English · DOAJ Scopus

    Background In older adults, obstructive sleep apnea (OSA) has been associated with several cardiovascular complications. Whether young patients diagnosed with OSA also are at higher risk of developing subsequent cardiovascular disease is uncertain. We aimed to estimate the risk of developing an…

  8. Journal Article

    Extended Anticoagulation After Pulmonary Embolism: A Multicenter Observational Cohort Analysis

    Romain Chopard; Ida Ehlers Albertsen; Fiona Ecarnot et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 11 No. 13 · 2022 · English · DOAJ Scopus

    Background Pulmonary embolism (PE) has a long‐term risk of adverse events, which can be prevented by extended anticoagulation. We compared clinical characteristics and outcomes between patients treated with 2‐year extended anticoagulation and those who were not, in a population who had completed an…

  9. Journal Article

    Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation

    Gregory Piazza; Shelley Hurwitz; Lindsay M. Harrigan et al.

    TH Open, Vol. 02 No. 01 · 2018 · English · DOAJ

    Abstract Atrial fibrillation (AF) is associated with an increased rate of mortality, heart failure, and stroke. We conducted an observational study to assess the relationship between anticoagulation and adverse clinical outcomes in hospitalized patients with AF. We performed a…

  10. Journal Article

    Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study

    Ida Ehlers Albertsen; Stavros V. Konstantinides; Gregory Piazza et al.

    TH Open, Vol. 06 No. 04 · 2022 · English · DOAJ

    Background Although men are considered at high risk for recurrent venous thromboembolism (VTE), sex-specific data on prognostic factors are lacking. We estimated the cumulative recurrence risks associated with clinical characteristics and comorbidities known or suspected to be associated with the…

  11. Journal Article

    Value‐Based Medicine in the Management of Abdominal Aortic Aneurysms

    Daniel Raskin; Sasan Partovi; Francis Caputo et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 15 No. 11 · 2026 · English · DOAJ Scopus

    The implementation of value‐based medicine reflects a transformation from volume incentivized care to a quality‐of‐care directed reimbursement model. Value‐based medicine aims to concurrently improve health care quality and control growing health care expenditures by aligning evidence‐based and…

  12. Journal Article

    β-Blockers after myocardial infarction with preserved or mildly reduced left ventricular ejection fraction: Fragility of contemporary evidence

    Marco Zuin; Roman Chopard; Douglas E. Drachman et al.

    American Heart Journal Plus, Vol. 67 · 2026 · English · DOAJ Scopus

    Background: β-Blockers have been traditionally prescribed after acute myocardial infarction (MI), but contemporary evidence in patients with preserved or mildly reduced left ventricular ejection fraction (LVEF ≥40%) have not provided consistent results. We assessed the robustness of the evidence…

  13. Journal Article

    Trends in Sudden Cardiac Death Among Adults Aged 25 to 44 Years in the United States: An Analysis of 2 Large US Databases

    Marco Zuin; Sanghamitra Mohanty; Rahul Aggarwal et al.

    Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol. 14 No. 1 · 2025 · English · DOAJ Scopus

    Background Sudden cardiac death (SCD) in early adults aged 25 to 44 years represents an important and unexpected cause of death. We assessed trends in SCD‐related mortality in the United States from 1999 to 2020 among early adults to determine differences by sex, ethnoracial groups, urbanization…

  14. Journal Article Full text

    Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19

    Gregory Piazza; Umberto Campia; Shelley Hurwitz et al.

    Journal of the American College of Cardiology · 2020 · English · OpenAlex Scopus

    BACKGROUND: Cardiovascular complications, including myocardial infarction, ischemic stroke, and pulmonary embolism, represent an important source of adverse outcomes in coronavirus disease-2019 (COVID-19). OBJECTIVES: To assess the frequency of arterial and venous thromboembolic disease, risk…

  15. Journal Article

    Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19

    Galit H. Frydman DVM, ScD; Edward W. Boyer MD, PhD; Rosalynn M. Nazarian MD et al.

    Clinical and Applied Thrombosis/Hemostasis, Vol. 26 · 2020 · English · DOAJ Scopus

    Severe acute respiratory syndrome coronavirus 2 infection (COVID-19) is known to induce severe inflammation and activation of the coagulation system, resulting in a prothrombotic state. Although inflammatory conditions and organ-specific diseases have been shown to be strong determinants of…

  16. Journal Article

    Cardiovascular-Kidney-Metabolic Syndrome-Attributable Mortality in the United States, From 2010 to 2023

    Marco Zuin, MD, MS; Raul Aggarwal, MD, PhD; Amit Khera, MD, MSc et al.

    JACC: Advances, Vol. 4 No. 12 · 2025 · English · DOAJ Scopus

    Background: Cardiovascular-kidney-metabolic syndrome (CKM) is increasingly prevalent in the United States, yet long-term nationwide data on CKM-attributable mortality remain limited. Objectives: This study analyzed CKM-attributable mortality trends in the United States from 2010 to 2019, focusing…

  17. Journal Article

    Effectiveness and safety of rivaroxaban vs warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study

    François Laliberté; Behnood Bikdeli; Veronica Ashton et al.

    Research and Practice in Thrombosis and Haemostasis, Vol. 9 No. 5 · 2025 · English · DOAJ Scopus

    Background: Limited data exist comparing the effectiveness and safety of rivaroxaban and warfarin in patients with right ventricular dysfunction (RVD), a common acute pulmonary embolism (PE) complication. Objectives: To assess the effectiveness and safety of rivaroxaban compared with warfarin among…